Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PROX1 Antikörper

PROX1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1589859
  • Target Alle PROX1 Antikörper anzeigen
    PROX1 (Prospero Homeobox 1 (PROX1))
    Reaktivität
    • 103
    • 48
    • 26
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 95
    • 8
    Kaninchen
    Klonalität
    • 93
    • 10
    Polyklonal
    Konjugat
    • 48
    • 10
    • 10
    • 9
    • 8
    • 7
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PROX1 Antikörper ist unkonjugiert
    Applikation
    • 93
    • 58
    • 42
    • 28
    • 13
    • 11
    • 10
    • 4
    • 2
    • 2
    Western Blotting (WB), Immunofluorescence (IF)
    Spezifität
    Recombinant human Prox-1
    Produktmerkmale
    Chromosomal location: 1q32.2-q32.3
    Isotyp
    IgG
    Top Product
    Discover our top product PROX1 Primärantikörper
  • Applikationshinweise
    Western Blot: use 1-5 µg/mL
    Kommentare

    Rabbit IG Polyclonal Antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
    Buffer
    0.5X PBS, pH 7.2
    Handhabung
    Centrifuge vial prior to opening. Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    The lyophilized antibody is stable at room temperature for up to 1 month. The reconstituted antibody is stable for at least two weeks at 2-8 °C. Frozen aliquots are stable for at least 6 months when stored at -20 °C.
    Haltbarkeit
    6 months
  • Lee, Koh: "Coordinated lymphangiogenesis is critical in lymph node development and maturation." in: Developmental dynamics : an official publication of the American Association of Anatomists, (2016) (PubMed).

    Quagliata, Klusmeier, Cremers, Pytowski, Harvey, Pettis, Thiele, Sleeman: "Inhibition of VEGFR-3 activation in tumor-draining lymph nodes suppresses the outgrowth of lymph node metastases in the MT-450 syngeneic rat breast cancer model." in: Clinical & experimental metastasis, Vol. 31, Issue 3, pp. 351-65, (2014) (PubMed).

    Kaltezioti, Antoniou, Stergiopoulos, Rozani, Rohrer, Politis: "Prox1 regulates Olig2 expression to modulate binary fate decisions in spinal cord neurons." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 34, Issue 47, pp. 15816-31, (2014) (PubMed).

    Sleeckx, Van Brantegem, Van den Eynden, Fransen, Casteleyn, Van Cruchten, Veldhuis Kroeze, Van Ginneken: "Angiogenesis in canine mammary tumours: a morphometric and prognostic study." in: Journal of comparative pathology, Vol. 150, Issue 2-3, pp. 175-83, (2014) (PubMed).

    Trindade, Torrelo, Kutzner, Requena, Tellechea, Colmenero: "An immunohistochemical study of angiokeratomas of children." in: The American Journal of dermatopathology, Vol. 36, Issue 10, pp. 796-9, (2014) (PubMed).

    Benevenuto de Andrade, Ramírez-Amador, Anaya-Saavedra, Martínez-Mata, Fonseca, Graner, Paes de Almeida: "Expression of PROX-1 in oral Kaposi's sarcoma spindle cells." in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, Vol. 43, Issue 2, pp. 132-6, (2014) (PubMed).

    Dartsch, Schulte, Hägerling, Kiefer, Vestweber: "Fusing VE-cadherin to ?-catenin impairs fetal liver hematopoiesis and lymph but not blood vessel formation." in: Molecular and cellular biology, Vol. 34, Issue 9, pp. 1634-48, (2014) (PubMed).

    Burger, Stuurman, Kok, Konijn, Schooneman, Niederreither, Coles, Agace, Christoffels, Mebius, van de Pavert, Bekker: "Involvement of neurons and retinoic acid in lymphatic development: new insights in increased nuchal translucency." in: Prenatal diagnosis, Vol. 34, Issue 13, pp. 1312-9, (2014) (PubMed).

    Buttler, Badar, Seiffart, Laggies, Gross, Wilting, Weich: "De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice." in: Cellular and molecular life sciences : CMLS, Vol. 71, Issue 8, pp. 1513-27, (2014) (PubMed).

  • Target
    PROX1 (Prospero Homeobox 1 (PROX1))
    Andere Bezeichnung
    Prox-1 (PROX1 Produkte)
    Synonyme
    xprox1 antikoerper, prospero antikoerper, PROX1 antikoerper, LOC100232600 antikoerper, A230003G05Rik antikoerper, prox1 antikoerper, zgc:111888 antikoerper, prospero homeobox 1 antikoerper, prospero homeobox 1 L homeolog antikoerper, prospero homeobox 1a antikoerper, PROX1 antikoerper, prox1.L antikoerper, prox1 antikoerper, Prox1 antikoerper, prox1a antikoerper
    Hintergrund
    Prox-1 is a homeobox gene and acts as a master switch for lymphatic endothelial phenotype. Expression of Prox-1 in blood endothelial cells induces expression of other lymphatic marker genes. Together with Podoplanin, Prox-1 can be used to reliably distinguish lymphatic vessels from blood vessels. Prox-1 is expressed in CNS, eye, pancreas, liver and heart, and it is one of the most specific and reliable markers for lymphatic endothelial cells. Produced from sera of rabbits immunized with the recombinant highly conserved C-terminal part of the homeobox transcription factor Prox-1.
    Synonyms: PROX1, W117m
    NCBI Accession
    NP_002754, NM_002763
    UniProt
    Q92786
    Pathways
    Stem Cell Maintenance, Regulation of Muscle Cell Differentiation
Sie sind hier:
Kundenservice